Bioavailability: Difference between revisions
Feedback

From WikiLectures

(minor)
No edit summary
 
(3 intermediate revisions by one other user not shown)
Line 6: Line 6:
*The route with the highest F (F=1) is via intravenous (I.V.) administration.  
*The route with the highest F (F=1) is via intravenous (I.V.) administration.  
*The second highest F is achieved through inhalation.  
*The second highest F is achieved through inhalation.  
*The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing *first pass metabolism, prior entering to the systemic circulation.     
*The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing first pass metabolism, prior entering to the systemic circulation.     


'''<big>Types</big>'''
'''<big>Types</big>'''


'''Absolute bioavailability'''
'''Absolute bioavailability'''
[[File:AUC_IVPO.svg| right | 250px |]]
[[File:AUC_IVPO.svg| right|250px|The plasma concentration (C) over time (t) graph]]
:It is the comparison of the per os F to the intravenous F
:It is the comparison of the per os F to the intravenous F
::<math> {F_{abs}} = {AUC_{P.O.} \times D_{I.V.}\over AUC_{I.V.}\times D_{P.O.}} </math>
::<math> {F_{abs}} = {{AUC_{P.O.} \times D_{I.V.}\over AUC_{I.V.}\times D_{P.O.}}\times 100 } </math>
:where
:where
::'''AUC<sub>P.O.</sub>''': area under the curve for the oral route
::'''AUC<sub>P.O.</sub>''': area under the curve for the oral route
Line 22: Line 22:
'''Relative bioavailability'''
'''Relative bioavailability'''
:It is the comparison of the per os F to another administration route, other than intravenous.
:It is the comparison of the per os F to another administration route, other than intravenous.
[[category: pharmacology]]

Latest revision as of 19:24, 14 February 2024

Definition

Bioavailability (F) is a pharmacokinetic parameter representing the fraction of a drug dose that reaches the systemic circulation unaltered.

Characteristics

  • The greater the F, the greater the amount of drug that reaches the systemic circulation, and thus the greater the drug concentration in plasma and vice versa
  • The route with the highest F (F=1) is via intravenous (I.V.) administration.
  • The second highest F is achieved through inhalation.
  • The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing first pass metabolism, prior entering to the systemic circulation.

Types

Absolute bioavailability

The plasma concentration (C) over time (t) graph
It is the comparison of the per os F to the intravenous F
where
AUCP.O.: area under the curve for the oral route
AUCI.V.: area under the curve for the intravenous route
DP.O.: dose administered from oral route
DI.V.: dose administers from intravenous route

Relative bioavailability

It is the comparison of the per os F to another administration route, other than intravenous.